Post-Treatment Lyme Disease Syndrome (PTLDS)
Controversial in conventional medicine is Post-Treatment Lyme Disease Syndrome (PTLDS), in which symptoms persist after completion of antibiotic borrelia treatment, which are often very unspecific and can affect many different organ systems. For example, chronic tiredness (fatigue), concentration problems, depression or general poor performance can occur alongside many other symptoms that are often diffuse and difficult to classify. This makes it difficult for conventional doctors to make a diagnosis, which is why the affected patients are often wrongly placed in the psychosomatic corner for several years and see many therapists without any visible therapeutic success. Part of our holistic healing concept is to take targeted action against a confirmed Borrelia infection or persistence, as well as to strengthen the milieu in order to unleash the body’s own defenses.
Like the syphilis pathogens, borrelia are great camouflage artists and are therefore easily overlooked. This is particularly the case when the classic symptoms of the disease do not appear at all or are misjudged.
Different forms in which the borrelia can survive in the body are also being discussed. In addition to the generally known, corkscrew-shaped spirochetes, there is talk of cystic forms and spore-like, completely metabolically inactive forms.
With a diagnosis that is not generally recognized, it is usually very difficult for those affected to receive appropriate treatment. Long courses are not uncommon, and it is often the case that a wide variety of specialists from all areas of medicine have been consulted without the patient improving significantly.
Conventional medicine has not yet been able to develop effective treatment approaches and strategies for the damage caused by long disease processes (secondary damage).
Lyme disease is currently treated in Germany according to the following guidelines of the Association of Scientific Medical Societies (AMWF):
AMWF Guideline Cutaneous Lyme borreliosis, AMWF Guideline Neuroborreliosis
In its “Klug Entscheiden” initiative, the German Society of Internal Medicine (DGIM) advises against determining Borrelia serology if there is no typical medical history and symptoms. Due to the high infection titer (seroprevalence), the probability of misdiagnosis (false positive test result) is too high.
This means that the 50% of infected people who have no clear symptoms or do not remember their tick bite unfortunately have less chance of early detection and treatment of Lyme disease.
Conventionally, only laboratory-confirmed infections are treated with antibiotics – depending on the stage and severity of the symptoms, treatment lasts between 5 and 30 days.